Taking stock of the drug industry, from the lab to the medicine chest

April 1, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Nardus Engelbrecht/AP Rollout of 'miracle' HIV prevention drug is threatened by Trump cuts to global AIDS relief program President's Emergency Plan for AIDS Relief had been set to lead distribution of lenacapavir, a "miracle" PrEP drug. By Ed Silverman and Jason Mast STAT+ | Trump's proposed tariffs may cause shortages of Canadian-made drugs in the U.S., analysis finds The looming threat of tariffs has the pharmaceutical industry, investors and consumer groups on edge and calculating the implications. By Ed Silverman Opinion: Reduce drug spending by drastically simplifying monopolies on drugs The current system of relying on an endless stream of worthless patents must be replaced with a single monopoly of fixed duration for each new drug. By Alfred Engelberg

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser